Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
about
Polypoidal choroidal vasculopathy: an update on therapeutic approachesRanibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysisHigh-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian populationCombined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review.
P2860
Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Two-year follow-up of ranibizu ...... poidal choroidal vasculopathy.
@en
type
label
Two-year follow-up of ranibizu ...... poidal choroidal vasculopathy.
@en
prefLabel
Two-year follow-up of ranibizu ...... poidal choroidal vasculopathy.
@en
P2093
P2860
P356
P1476
Two-year follow-up of ranibizu ...... poidal choroidal vasculopathy.
@en
P2093
Hiroshi Goto
Masahiro Miura
Rei Nemoto
Takuya Iwasaki
P2860
P304
P356
10.2147/OPTH.S37252
P407
P577
2012-10-08T00:00:00Z